Latest Whitepapers
Whitepaper
Advances in Cell Therapy
This article examines recent advancements in cell therapy research, from promising lab findings poised for clinical translation to enhancements in development, testing, and manufacturing processes.
Whitepaper
Enhancing Immune Cell Cytotoxicity and Persistence Insights Using Real-Time Cell Analysis
Cell therapies, from regenerative medicine to immunotherapy, are transforming the medical landscape with 75 already approved globally and over 2,000 in development.
Whitepaper
Embracing Data-Driven Modeling Approaches Into Biopharmaceutical Processing
This article explores new workflows using data-driven modeling to improve culture medium and new control algorithms allowing for better modulation within the bioprocess design space.
Whitepaper
Improving Cancer Patient Care With Professor Mark Lawler
In this article, Mark Lawler, professor of digital health, answers your questions about these revolutionary techniques and discusses the barriers to their implementation in the clinic. Prof. Lawler has an international reputation in cancer research and a focus on developing a molecular understanding of cancer to improve patient care, including through precision medicine.
Whitepaper
Cell Culture – Good Practice and Advanced Methods
This article explores how quality control can improve protocol standardization, enhance scalability and ensure that cultures meet regulatory criteria.
Whitepaper
Applications of Mass Spectrometry in Biopharmaceutical Analysis
The sensitivity and specificity of mass spectrometry (MS) has made it an indispensable tool for biopharmaceutical analysis, ensuring the safety and efficacy of biologics.
Whitepaper
New Analysis Tools for Detecting Food Fraud
The increasing threat of food fraud is driving the development of new and more powerful combined approaches that can “fingerprint” food constituents to stay ahead of the game.
Whitepaper
High-Throughput Screening Methods for Drug Discovery
Due to the sheer number of possible compounds available, pharmaceutical companies have been adopting high-throughput screening (HTS) methods that can screen chemical libraries rapidly and inexpensively to identify the most promising compounds with activity against a specific biological target.
Whitepaper
Advanced Oncology Treatment Candidates Developed With Next-Generation Preclinical Models
One factor that can significantly impact the success of oncology drug development is the preclinical model used. The right model can provide valuable insights into key interactions within the body and help researchers to better understand how tumors respond to treatment.
Whitepaper
Expediting Drug Discovery Using Novel Target-Based Approaches
Innovative strategies to shorten the research and development cycle, increase process efficiency and expedite the drug discovery process are needed.
Advertisement